Senhwa Biosciences, Inc. announced that Taiwan Food and Drug Administration has approved its Phase II IND application of Silmitasertib to treat patients with community-acquired pneumonia caused by.
The ASUS VivoWatch: Modern platform for health management digitimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from digitimes.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ IAS – the International AIDS Society – in partnership with Gilead Sciences, announced 18 Champions of the 2023 Me and My Healthcare Provider.
IAS – the International AIDS Society – in partnership with Gilead Sciences, announced 18 Champions of the 2023 Me and My Healthcare Provider (MMHCP) campaign from Brazil, Hong Kong, Mexico and Taiwan. This distinguished award celebrates frontline healthcare workers who have made a difference in the lives of people living with HIV by delivering stigma-free HIV prevention, treatment, and care services.